Indeed, in colorectal cancer, while increased EphB4 expression is associated with longer patient survival [46], inhibition of EphB4 leads to decreased cell proliferation and metastasis and expression of EphB4 enhances tumor growth [24]. This evidence concerns the gene EPHB4 and neoplasm.